Signaturefd LLC Has $558,000 Stock Position in Koninklijke Philips (NYSE:PHG)

Signaturefd LLC reduced its position in shares of Koninklijke Philips (NYSE:PHG) by 2.0% in the 4th quarter, Holdings Channel reports. The firm owned 23,932 shares of the technology company’s stock after selling 488 shares during the period. Signaturefd LLC’s holdings in Koninklijke Philips were worth $558,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Brandywine Global Investment Management LLC bought a new stake in shares of Koninklijke Philips during the third quarter worth $36,544,000. Envestnet Asset Management Inc. grew its stake in shares of Koninklijke Philips by 29.4% during the third quarter. Envestnet Asset Management Inc. now owns 1,447,942 shares of the technology company’s stock worth $28,872,000 after buying an additional 328,922 shares during the last quarter. Employees Retirement System of Texas bought a new stake in shares of Koninklijke Philips during the third quarter worth $4,323,000. FMR LLC grew its stake in shares of Koninklijke Philips by 1.7% during the third quarter. FMR LLC now owns 9,516,906 shares of the technology company’s stock worth $189,767,000 after buying an additional 155,055 shares during the last quarter. Finally, Barclays PLC bought a new stake in shares of Koninklijke Philips during the third quarter worth $2,310,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Koninklijke Philips Stock Performance

Shares of Koninklijke Philips stock opened at $20.97 on Thursday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.20 and a quick ratio of 0.78. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $24.27. The company’s fifty day moving average is $20.41 and its 200 day moving average is $20.89.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Monday, January 29th. The technology company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.03. Koninklijke Philips had a negative net margin of 2.53% and a positive return on equity of 14.17%. The company had revenue of $5.45 billion for the quarter, compared to analysts’ expectations of $5.47 billion. On average, sell-side analysts predict that Koninklijke Philips will post 1.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. BNP Paribas cut shares of Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research note on Wednesday, February 7th. StockNews.com raised shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research note on Thursday, February 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.